ABOUT US

Environmental, Social and Governance

« I strongly believe that the success of our company relies in its capacity to adapt to tomorrow’s challenges.

Our responsibility as a company is to provide sustainability and resilience to the pharmaceutical value chain. »

Karl Rotthier, Chief Executive Officer

A collaborative approach

Building a unique ESG strategy requires diverse input. So, we opened a dialogue with more than 1,200 internal and external stakeholders in 30 countries through a survey.

Employees, clients, suppliers, investors, non-profits and others were called upon to share what they expect from an innovative, sustainable industry leader. Their insight was invaluable and gave us a well-rounded foundation for shaping our key commitments.

The findings of our global survey helped to define our ESG priorities. The resounding takeaway was that expectations are at an all-time high. We look forward to rising to the occasion. We’ve identified a range of priorities, which align along 4 commitments.

Our four commitments

Our stakeholders

ESG is about taking our stakeholders expectations into our strategy. Who are they?

Materiality matrix

What are our stakeholders most material expectations?

Resource center

Download documents

Placeholder white background